Published in J Biol Chem on April 07, 2000
Genetic engineering of algae for enhanced biofuel production. Eukaryot Cell (2010) 2.97
HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol (2008) 1.40
Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2). J Lipid Res (2010) 1.35
Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol (2010) 1.13
Biliary cholesterol secretion: more than a simple ABC. World J Gastroenterol (2010) 1.12
Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol (2015) 1.11
Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol. Clin Transl Sci (2009) 1.10
Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice. J Lipid Res (2009) 1.05
Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Circulation (2011) 1.03
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. Arterioscler Thromb Vasc Biol (2008) 1.00
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man. J Exp Med (2007) 0.97
Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein. PLoS One (2009) 0.94
The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002). J Lipid Res (2008) 0.92
Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Biochem Pharmacol (2010) 0.91
The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo. Arterioscler Thromb Vasc Biol (2009) 0.91
ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma. J Lipid Res (2012) 0.89
Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism. J Biol Chem (2009) 0.88
Fish oil promotes macrophage reverse cholesterol transport in mice. Arterioscler Thromb Vasc Biol (2009) 0.88
Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL. Biochim Biophys Acta (2014) 0.86
Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury. CNS Neurol Disord Drug Targets (2008) 0.84
Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis. J Biol Chem (2014) 0.83
Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. J Lipid Res (2011) 0.83
Role of secretory phospholipase A₂ in women with metabolic syndrome. Indian J Med Res (2013) 0.83
Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis. Sci Rep (2015) 0.82
PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI. Biochem Pharmacol (2011) 0.81
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis? Vasc Health Risk Manag (2008) 0.80
Human luteinized granulosa cells secrete apoB100-containing lipoproteins. J Lipid Res (2010) 0.80
ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. Mediators Inflamm (2006) 0.79
High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport. Sci Rep (2017) 0.78
Cell Surface and Membrane Engineering: Emerging Technologies and Applications. J Funct Biomater (2015) 0.78
Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma. Oncotarget (2015) 0.78
Role of suppressor of cytokine signaling-1 in murine atherosclerosis. PLoS One (2012) 0.77
Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA. Inflammation (2004) 0.76
A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice. Mamm Genome (2013) 0.76
Phospholipase A2 mediates apolipoprotein-independent uptake of chylomicron remnant-like particles by human macrophages. Int J Vasc Med (2011) 0.75
Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism. J Am Heart Assoc (2016) 0.75
A Western-fed diet increases plasma HDL and LDL-cholesterol levels in apoD-/- mice. PLoS One (2014) 0.75
Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition. Dis Model Mech (2015) 0.75
Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc (1999) 3.32
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet (1994) 3.22
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14
Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation (1999) 2.84
Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta (1981) 2.77
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet (1999) 2.56
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest (1999) 2.54
Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med (1982) 2.33
Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem (1986) 2.25
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science (1992) 2.24
Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol (1979) 2.08
Hip arthroscopy for acetabular labral tears. Arthroscopy (1999) 2.08
Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J (1982) 2.07
Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature (1993) 2.05
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest (2001) 2.04
Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol (2000) 2.02
Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol (1991) 2.01
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med (1998) 1.98
Hip arthroscopy by the lateral approach. Arthroscopy (1987) 1.94
Amyloid P component is located on elastic fibre microfibrils in normal human tissue. Nature (1981) 1.70
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology (1982) 1.67
The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest (1997) 1.67
Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax (1984) 1.65
Biology of serum amyloid P component. Ann N Y Acad Sci (1982) 1.65
The prevention and treatment of ankle injuries. Am J Sports Med (1977) 1.61
MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum Hered (2004) 1.59
Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med (1981) 1.53
Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest (1995) 1.52
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation (2001) 1.46
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol (2000) 1.43
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res (1999) 1.40
Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol (1982) 1.39
Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus. Atherosclerosis (2001) 1.39
SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem (1998) 1.38
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37
Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol (1982) 1.37
Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. J Lipid Res (1995) 1.35
Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem (1992) 1.33
Mixed modelling to characterize genotype-phenotype associations. Stat Med (2005) 1.31
Niemann-Pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization. Proc Natl Acad Sci U S A (1999) 1.30
Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res (1995) 1.30
Complete airway obstruction during arthroscopic shoulder surgery. Anesth Analg (1993) 1.27
Letter: Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med (1974) 1.23
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem (2001) 1.23
Arthroscopically assisted excision of osteoid osteoma involving the hip. Arthroscopy (2001) 1.21
Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res (1995) 1.20
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest (1993) 1.17
Metabolism and binding of aromatic hydrocarbons in the lung. Relationship to experimental bronchiolar necrosis. Am Rev Respir Dis (1973) 1.17
Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. J Exp Med (1984) 1.17
Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (1999) 1.16
Characterization of a bile salt-dependent cholesteryl ester hydrolase activity secreted from HepG2 cells. Biochim Biophys Acta (1992) 1.16
Generation of biologically active C-reactive protein peptides by a neutral protease on the membrane of phorbol myristate acetate-stimulated neutrophils. J Immunol (1989) 1.15
Identification of three isoform patterns of human serum amyloid A protein. Biochem J (1988) 1.14
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest (1994) 1.14
The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score. J Thromb Haemost (2007) 1.11
Diurnal variation of erythrocyte sedimentation rate related to feeding. Lancet (1982) 1.10
Inflammatory markers of coronary risk. N Engl J Med (2000) 1.10
Regulation of protein synthesis in Tetrahymena. RNA sequence sets of growing and starved cells. J Biol Chem (1983) 1.10
Structural prerequisites for serum amyloid A fibril formation. J Biol Chem (1993) 1.08
Detection of susceptibility to coronary disease. Bull N Y Acad Med (1969) 1.07
Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res (1994) 1.07
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest (1995) 1.07
Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI. J Biol Chem (2001) 1.06
Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg (1996) 1.06
Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol Ther (2000) 1.05
Three day neonatal thymectomy selectively depletes NK1.1+ T cells. Int Immunol (1998) 1.05
Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice. J Lipid Res (2000) 1.05
Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine (2000) 1.04
Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production. Biochem J (1989) 1.03
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest (1993) 1.03
Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop. Circulation (2001) 1.03
ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J Clin Invest (1999) 1.03
Purification and properties of tRNA(adenine-1)-methyltransferase from rat liver. J Biol Chem (1977) 1.02
Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J Lipid Res (2000) 1.02
Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions. Proc Natl Acad Sci U S A (1986) 1.02
Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J Lipid Res (1998) 1.01
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol (1999) 1.01
Alternative forms of the scavenger receptor BI (SR-BI). J Lipid Res (1997) 1.01
Characterization of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol (1993) 1.00
Serum amyloid A protein in familial Mediterranean fever. Ann Intern Med (1985) 1.00
A 30-amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfide-isomerase and causes abetalipoproteinemia. J Biol Chem (1995) 1.00
Production of monoclonal antibodies against chicken Pop1 (BVES). Hybrid Hybridomics (2001) 0.98
cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J7774 macrophages. J Biol Chem (1991) 0.98
Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J Lipid Res (2001) 0.98
Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J Lipid Res (1983) 0.98
The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab (1999) 0.98
Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem (1989) 0.97
Precision acromioplasty in arthroscopic subacromial decompression of the shoulder. Arthroscopy (1991) 0.97
Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res (1993) 0.96
Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Curr Opin Pharmacol (2001) 0.96
Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice. J Exp Med (1992) 0.95
Identification of a novel serum amyloid A protein in BALB/c mice. Biochem J (1991) 0.95
Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice. Mol Ther (2000) 0.95